BIDU vs TTWO

Baidu's financial health is strong with a Piotroski F-Score of 7/9, indicating solid operational performance and balance sheet strength. However, the lack of an Altman Z-Score prevents a full distress risk assessment, while declining revenue and earnings growth raise concerns about future momentum. Despite a current price of $161.44 trading near its Graham Number of $167.2, the stock shows mixed signals with weak profitability metrics like ROE (3.08%) and low profit margins (6.90%) relative to sector peers. Analysts maintain a 'buy' recommendation with a target of $171.54, supported by recent earnings beat trends, though decelerating fundamentals and bearish technicals temper near-term optimism.

The deterministic health profile is weak, highlighted by a Piotroski F-Score of 2/9, indicating significant operational and financial instability. While the company exhibits strong top-line revenue growth of 24.9% and maintains a 'strong_buy' analyst consensus with a target price of $276.74, these are countered by a severe profit margin of -60.45% and bearish insider activity. The stock is currently trading as a growth play on future catalysts rather than current fundamentals, as evidenced by the high Price/Book ratio of 11.48 and a lack of positive earnings consistency.